Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Wierenga Wendell

Over the trailing 90 days, Wierenga Wendell (Director at CYTOKINETICS INC) traded $359K of stock (net selling $246K) across 2 companies, per 8 SEC Form 4 transactions.

Role
Director
Companies
CYTK CRNX
Window
Trailing 90 days · 8 transactions · CIK 1239956
Net activity
−$246K ($56K bought · $302K sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
CYTKCYTOKINETICS INC6$56K$302K−$246K
CRNXCrinetics Pharmaceuticals, Inc.2$0

Transactions (8)

DateSymbolTypeSharesValueDescription
2026-07-15CYTKBuy75$6KGrant, award or other acquisition
2026-06-18CRNXBuy5.9K$0Grant, award or other acquisition
2026-06-18CRNXBuy9.7K$0Grant, award or other acquisition
2026-05-27CYTKBuy4.3K$0Grant, award or other acquisition
2026-05-27CYTKBuy2.9K$0Grant, award or other acquisition
2026-05-05CYTKSell4.0K$302KOpen market or private sale
2026-05-05CYTKSell4.0K$0Exercise or conversion of derivative security
2026-05-05CYTKBuy4.0K$50KExercise or conversion of derivative security

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Wierenga's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free